CN(C)CCc1ccc(Nc2nccc(-c3c(-c4cccc(C(O)CO)c4)nc4ccccn34)n2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?